tRF-02514 promotes Parkinson's disease (PD) by inhibiting autophagy through targeting ATG5, thereby enhancing inflammatory cytokine release from microglia, inducing pyroptosis, and accelerating neuronal loss [83]. The gene discussed is ATG5; the disease is Parkinson disease.